P4HA2 may affect the STAT1/PD-L1 pathway to promote the development and inhibit antitumor immunity of colorectal cancer by binding to and downregulating the expression of STAT1, which may reveal a new pathogenic mechanism. This evidence concerns the gene STAT1 and colorectal cancer.